LRMR

Larimar Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Flynn James EDirector, 10 Percent Owner, Other: * Director By Deputization
$10M2M shares
BuyFeb 27, 2026
$5.00
--
Flynn James EDirector, 10 Percent Owner, Other: * Director By Deputization
$5.4M1.1M shares
BuyFeb 27, 2026
$5.00
--
Flynn James EDirector, 10 Percent Owner, Other: * Director By Deputization
$5.4M1.1M shares
BuyFeb 27, 2026
$5.00
--
Flynn James EDirector, 10 Percent Owner, Other: * Director By Deputization
$4.2M832k shares
BuyFeb 27, 2026
$5.00
--
Hamilton Thomas EdwardDirector
$500k100k shares
BuyFeb 27, 2026
$5.00
--
Sherman Jeffrey WDirector
$25k5k shares
BuyFeb 27, 2026
$5.00
--

News

globenewswire.comLarimar Therapeutics Reports First Quarter 2026 Financial and Business Updateglobenewswire.comMay 14globenewswire.comLarimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich's Ataxiaglobenewswire.comApr 30defenseworld.netLarimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of “Buy” by Brokeragesdefenseworld.netApr 27